On May 6, 2025, Leidos Holdings Inc (LDOS, Financial) released its 8-K filing for the first quarter of fiscal year 2025, showcasing impressive financial performance. The company, a leader in technology, engineering, and science solutions for defense, intelligence, civil, and health markets, reported revenues of $4.25 billion, marking a 7% increase year-over-year. This figure slightly exceeded the analyst estimate of $4.247 billion. Net income for the quarter was $365 million, translating to $2.77 per diluted share, surpassing the estimated earnings per share (EPS) of $2.47.
Leidos Holdings Inc (LDOS, Financial) demonstrated significant growth in its financial metrics, with a notable 30% year-over-year increase in non-GAAP diluted EPS to $2.97. The company's adjusted EBITDA reached $601 million, reflecting a 23% increase from the previous year, with an adjusted EBITDA margin of 14.2%, up from 12.3%. These achievements underscore Leidos' effective execution of its NorthStar 2030 Strategy, which focuses on enhancing customer outcomes through innovative technologies.
Our robust first quarter results build on the momentum from 2024, demonstrating the team's ability to execute in a dynamic environment that demands agility and innovation," stated Leidos Chief Executive Officer Tom Bell.
Leidos Holdings Inc (LDOS, Financial) reported a net income margin of 8.6%, an improvement from 7.1% in the first quarter of 2024. The company's cash flows from operations were $58 million, with a free cash flow of $36 million. The strong EBITDA and collections performance were key drivers of the operating cash flow. Additionally, Leidos issued $1 billion in senior unsecured notes to refinance existing debt and fund a $500 million accelerated share repurchase, reflecting confidence in its strategic positioning.
The company's four reportable segments—National Security & Digital, Health & Civil, Commercial & International, and Defense Systems—each contributed to the revenue growth. Notably, the Health & Civil segment saw an 8% increase in revenues, driven by higher volumes and case complexity in managed health services. Leidos also secured several significant contracts, including a $205 million task order with the Defense Threat Reduction Agency and a $148 million contract with the U.S. Air Force for Project Night Owl.
Leidos Holdings Inc (LDOS, Financial) continues to demonstrate resilience and adaptability in a competitive industry. The company's strategic investments in technology and its focus on customer-centric solutions are pivotal to its sustained growth. The reaffirmation of its full-year guidance, with expected revenues between $16.90 billion and $17.30 billion, further emphasizes its strong market position. As Leidos advances its strategic initiatives, it remains well-positioned to capitalize on emerging opportunities in the defense and technology sectors.
Explore the complete 8-K earnings release (here) from Leidos Holdings Inc for further details.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。